InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc.

XERS Clue Score53
United States Fiscal year ends December CIK 0001867096 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Kevin McCulloch
13 Jun 2025
See Remarks
Buy
25,000
$4.38
$109.48K
John P. Schmid
12 Aug 2024
Director
Buy indirect
4,515
$2.25
$10.15K
John P. Schmid
9 Aug 2024
Director
Buy indirect
4,285
$2.37
$10.13K
John P. Schmid
10 May 2024
Director
Buy indirect
5,400
$1.91
$10.31K
John P. Schmid
14 Mar 2024
Director
Buy indirect
4,500
$2.16
$9.72K
Jeffrey W Sherman
27 Nov 2023
Director
Buy indirect
5,400
$1.87
$10.10K
Steven Pieper
20 Nov 2023
See Remarks
Buy
28,000
$1.95
$54.60K
Dawn Halkuff
20 Nov 2023
Director
Buy indirect
5,410
$1.84
$9.95K
John Patrick Shannon Jr
17 Nov 2023
See Remarks
Buy
30,769
$1.64
$50.40K
John P. Schmid
16 Nov 2023
Director
Buy indirect
6,500
$1.51
$9.82K
Marla Persky
14 Nov 2023
Director
Buy indirect
6,370
$1.58
$10.06K
Paul R Edick
9 Aug 2023
See Remarks
Buy
10,000
$2.38
$23.79K
Paul R Edick
13 Dec 2022
See Remarks
Buy
20,000
$1.45
$29.00K
Paul R Edick
12 May 2022
See Remarks
Buy
100,000
$1.40
$140.38K
Paul R Edick
15 Nov 2021
See Remarks
Buy indirect
20,000
$2.28
$45.66K
John Patrick Shannon Jr
12 Nov 2021
See Remarks
Buy
60,000
$2.10
$126.00K
Paul R Edick
11 Nov 2021
See Remarks
Buy
200,000
$2.08
$415.76K
John Patrick Shannon Jr
11 Nov 2021
See Remarks
Buy
40,000
$2.09
$83.50K
Steven Pieper
10 Nov 2021
See Remarks
Buy
25,000
$2.00
$49.92K
Show all 68 transactions →

What was left out

Form 4 filings counted 156
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 33
Sales straight out of an exercise 4
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 17,798,318
History held since 5 Oct 2021